Researchers identify therapy that shrinks tumors in patients with multiple myeloma
Wednesday, March 8, 2017 - 15:31
in Health & Medicine
An experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma, report scientists.